Novo Nordisk remains a dominant business with a strong pipeline, and current multiples are low enough to justify a buy. Read my latest analysis of NVO stock.

BLOOMINGTON – Indiana used another hyper-efficient offensive performance to pull away from Milwaukee, 101-70, at Assembly Hall on Wednesday behind 24 points for Lamar Wilkerson and 21 from Tayton ...

Kevin projects the top 10 fantasy baseball dynasty catchers going into the 2029 MLB season. His top MLB catcher prospects to ...

Thank you, Paul. The continued momentum in both our U.S. and international businesses during Q3 saw over 14 million average ...

Today's post is all about the scalability of Office Scripting in Microsoft Excel using the Run Script action in Power ...

Week 11 has the chance to be a lot of fun in Fantasy and reality. For starters, Jameis Winston is back as the quarterback for ...

Gilead's Phase 3 ARTISTRY-1 trial shows its single-tablet HIV regimen of bictegravir and lenacapavir matches the efficacy and safety of current therapy.

Unlock the four zones of AI readiness and discover why sandboxing is the smartest strategy for executive-led transformation.

Gilead (GILD) announced topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of adults with ...